APA (7th ed.) Citation

PCE, S., FLJ, V., BG, N., M, T., MG, v. d. M., YM, R., . . . C, K. (2025). Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and intensity of lipid-lowering therapy in patients with established cardiovascular disease. Atherosclerosis, 408, 120411. https://doi.org/10.1016/j.atherosclerosis.2025.120411

Chicago Style (17th ed.) Citation

PCE, Schuitema, Visseren FLJ, Nordestgaard BG, Teraa M, van der Meer MG, Ruigrok YM, Onland-Moret NC, and Koopal C. "Elevated Triglycerides Are Related to Higher Residual Cardiovascular Disease and Mortality Risk Independent of Lipid Targets and Intensity of Lipid-lowering Therapy in Patients with Established Cardiovascular Disease." Atherosclerosis 408 (2025): 120411. https://doi.org/10.1016/j.atherosclerosis.2025.120411.

MLA (9th ed.) Citation

PCE, Schuitema, et al. "Elevated Triglycerides Are Related to Higher Residual Cardiovascular Disease and Mortality Risk Independent of Lipid Targets and Intensity of Lipid-lowering Therapy in Patients with Established Cardiovascular Disease." Atherosclerosis, vol. 408, 2025, p. 120411, https://doi.org/10.1016/j.atherosclerosis.2025.120411.